Anzeige der Dokumente mit ähnlichem Titel, Autor, Urheber und Thema.

• Targeting neuroendocrine prostate cancer: Molecular and clinical perspectives 

  Vlachostergios, P. J.; Papandreou, C. N. (2015)

  Neuroendocrine prostate carcinoma, either co-present with the local adenocarcinoma disease or as a result of transdifferentiation later in time, was described as one major process of emerging resistance to androgen deprivation ...
• Differential expression of hypoxia-inducible factor 1 alpha in non-small cell lung cancer and small cell lung cancer 

  Karetsi, E.; Ioannou, M. G.; Kerenidi, T.; Minas, M.; Molyvdas, P. A.; Gourgoulianis, K. I.; Paraskeva, E. (2012)

  OBJECTIVES: The aim of this study was to compare the expression of hypoxia-inducible factor 1 alpha and vascular endothelial growth factor in small cell lung cancer and subtypes of non-small cell lung cancer and examine ...
• HIF-2α phosphorylation by CK1δ promotes erythropoietin secretion in liver cancer cells under hypoxia 

  Pangou E., Befani C., Mylonis I., Samiotaki M., Panayotou G., Simos G., Liakos P. (2016)

  Hypoxia inducible factor 2 (HIF-2) is a transcriptional activator implicated in the cellular response to hypoxia. Regulation of its inducible subunit, HIF-2α (also known as EPAS1), involves posttranslational modifications. ...